Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
Holders of 5% or more of ARVN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Arvinas, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.90%5.42M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
| D. E. Shaw & Co, L.P. | 13G | 5.30%3.41M shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on Arvinas, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 28, 20264:15 PM ET | Vanguard Portfolio Management LLC | 13G | 6.12%3.92M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20263:43 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −12.15 ppfrom 12.15%Below 5% | Mar 13, 2026 | SEC |
| Nov 14, 20254:09 PM ET | D. E. Shaw & Co, L.P.and 2 others | 13G | 5.30%3.41M shares | New | Nov 6, 2025 | SEC |
| Nov 14, 20254:08 PM ET | Citadel Advisors LLCand 6 others | 13G/A | 0.40%264.2K shares | −4.70 ppfrom 5.10%Below 5% | Sep 30, 2025 | SEC |
| Oct 15, 20255:18 PM ET | Logos Global Management LPand 7 others | 13D/A | 3.40%2.50M shares | −5.20 ppfrom 8.60%Below 5% | Oct 13, 2025 | SEC |
| Aug 22, 20254:44 PM ET | Logos Global Management LPand 7 others | 13D/A | 8.60%6.30M shares | +2.20 ppfrom 6.40% | Aug 15, 2025 | SEC |
| Aug 14, 20251:07 PM ET | Price T Rowe Associates Inc | 13G/A | 1.90%1.33M shares | –Below 5% | Jun 30, 2025 | SEC |
| Jun 16, 20256:10 PM ET | Logos Global Management LPand 7 others | 13D | 6.40%4.80M shares | New | Jun 9, 2025 | SEC |
| May 15, 20251:56 PM ET | EcoR1 Capital, LLCand 2 others | 13G/A | 0.00%0 shares | –Below 5% | Mar 31, 2025 | SEC |
| Apr 30, 202510:58 AM ET | Vanguard Group Inc | 13G/A | 12.15%8.36M shares | – | Mar 31, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 7.90%5.42M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20255:24 PM ET | Citadel Advisors LLCand 6 others | 13G/A | 5.10%3.48M shares | 0.00 ppfrom 5.10% | Jan 23, 2025 | SEC |
| Jan 30, 20254:09 PM ET | Citadel Advisors LLCand 6 others | 13G | 5.10%3.48M shares | New | Jan 23, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Arvinas, Inc. shares.
No Form 144 notices for Arvinas, Inc. are on file.